HerSolution may interact with antipsychotics, carbamazepine, estrogen, lithium, SSRIs, triazolam, and valproic acid due to the inclusion of DHEA.7 The DHEA in HerSolution might also worsen psychiatric disorders and increase the risk of mania in those with mood disorders
Integrated Triple-Pathway Research Applications Amplified GH Pulsatility and Somatotroph Secretory Dynamics The convergent activation of cAMP/PKA signaling through dual GHRH receptor engagement and IP3/calcium mobilization through GHS-R1a stimulation produces a maximally amplified somatotroph GH secretory response the central research utility of this triple-peptide architecture
In the COR-I clinical trial, participants taking the maximum dose of Contrave lost an average of 5 to 6% of their body weight over 56 weeks compared to placebo group
Supports joint cartilage and bone density
Biochimica et Biophysica Acta (BBA) - General Subjects , 1830(5), 3289-3303